A Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP7570

NCT06000891 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

84

Enrollment

INDUSTRY

Sponsor class

Stopped Decision by Sponsor; LSLV was completed on 21-Mar-2025 as planned.

Conditions

Safety and Tolerability

Interventions

DRUG: ZP7570
DRUG: Placebo

Sponsor

Zealand Pharma

Collaborators

[object Object]